Skip to main content
LIPID MAPS®
menu
Databases
LMSD
LMPD
COMP_DB
LMISSD
Ion Mobility
Partial Spectra DB
Standards Spectra DB
Oxidized Phospholipid DB
Shorthand DB
Pathways
Reactions Explorer
LIPID MAPS® Pathways
SphinGOMAP©
Cayman Pathway Maps
Tools
Lipidomics
Tool Guide
MS Analysis
Structure
Drawing
Statistical
Analysis
Nomenclature
Tools
Lipid Analysis
Software
Education
Webinars
Podcasts
Tutorials
Resources
Classification
Nomenclature
Structure
Methods and
Protocols
Training
School
Community
Lipid of the
Month
Lipid Matters
Blog
Highlights
LipidWeb
Newsletters
External
Resources
Events Calendar
About
About Us
About Our
Partners
About Our
Sponsors
Sponsor Us
Contact Us
Archive
Downloads
Downloads Hub (All)
Experimental Data
REST
SPARQL
LMSD
LMPD
COMP_DB
PARTIAL_DB
Standards Spectra DB
login
Login
Microarray analysis of bone marrow-derived macrophage cells treated with Kdo
2
-lipid A (KLA) and ATP
Search by fold change ratio
|
Search by KEGG pathway
|
Search by LIPID MAPS lipid pathway
Kdo
2
-Lipid A / ATP gene array data - treatment:control ratios
KEGG pathway: Legionellosis (mmu05134)
Legend:
: View data/graphs for replicates
Gene symbol  
Time course plot
Accession
Description
Treatment
15min
30min
1hr
2hr
4hr
8hr
20hr
Apaf1
KLA
ATP
ATP+KLA
NM_001042558
apoptotic peptidase activating factor 1 (Apaf1), transcript variant 1, mRNA [NM_001042558]
KLA
2.92
2.81
3.22
2.74
2.42
1.74
1.40
ATP
1.05
.99
.87
.81
1.61
2.03
1.46
KLA/ATP
2.90
2.78
2.01
1.69
1.56
2.77
2.73
Arf1
KLA
ATP
ATP+KLA
NM_007476
ADP-ribosylation factor 1 (Arf1), mRNA [NM_007476]
KLA
1.09
1.20
1.18
1.14
1.26
1.31
1.28
ATP
1.05
1.19
.94
1.23
1.10
.97
1.18
KLA/ATP
1.22
1.22
.94
1.36
1.07
1.16
1.29
Bcl2l13
KLA
ATP
ATP+KLA
NM_153516
BCL2-like 13 (apoptosis facilitator) (Bcl2l13), nuclear gene encoding mitochondrial protein, mRNA [NM_153516]
KLA
.82
.88
.83
.75
.78
1.00
1.48
ATP
1.01
1.07
1.06
1.10
.84
1.30
1.52
KLA/ATP
.83
.86
.78
.83
.70
1.60
2.37
Birc1f
KLA
ATP
ATP+KLA
NM_010871
baculoviral IAP repeat-containing 1f (Birc1f), mRNA [NM_010871]
KLA
1.23
1.26
1.49
1.28
1.40
1.41
1.45
ATP
1.18
1.18
1.05
1.15
.78
.76
1.02
KLA/ATP
1.49
1.45
1.18
1.27
.75
.94
1.14
Bnip3
KLA
ATP
ATP+KLA
NM_009760
BCL2/adenovirus E1B interacting protein 1, NIP3 (Bnip3), nuclear gene encoding mitochondrial protein, mRNA [NM_009760]
KLA
.90
1.03
.99
.91
1.00
1.23
1.94
ATP
.99
1.01
1.09
1.08
1.01
1.56
.98
KLA/ATP
.89
.95
.93
1.19
1.26
1.15
1.86
C3
KLA
ATP
ATP+KLA
NM_009778
complement component 3 (C3), mRNA [NM_009778]
KLA
28.58
25.57
24.39
27.34
23.38
23.21
18.10
ATP
1.04
.93
1.21
1.90
2.80
5.74
12.19
KLA/ATP
27.04
26.10
33.29
23.09
25.65
23.77
40.22
Casp1
KLA
ATP
ATP+KLA
NM_009807
caspase 1 (Casp1), mRNA [NM_009807]
KLA
4.27
4.63
5.39
6.07
5.87
5.49
2.96
ATP
.93
.87
1.01
.80
1.05
3.11
2.77
KLA/ATP
4.31
4.18
5.40
4.00
4.66
4.90
7.20
Casp3
KLA
ATP
ATP+KLA
NM_009810
caspase 3 (Casp3), mRNA [NM_009810]
KLA
1.66
1.94
2.47
2.61
3.01
2.96
1.44
ATP
.90
.99
1.17
1.30
1.01
1.17
.86
KLA/ATP
1.55
1.87
2.40
2.35
2.27
2.84
2.52
Casp3
KLA
ATP
ATP+KLA
U49929
ICE-like cysteine protease (Lice) mRNA, complete cds. [U49929]
KLA
1.71
1.87
2.69
3.11
3.64
3.42
1.52
ATP
1.04
1.07
1.16
1.34
.98
1.27
.86
KLA/ATP
1.80
1.96
2.46
2.91
2.50
3.24
3.10
Casp7
KLA
ATP
ATP+KLA
NM_007611
caspase 7 (Casp7), mRNA [NM_007611]
KLA
3.50
3.60
4.52
5.05
5.20
2.96
1.27
ATP
1.03
1.14
1.20
1.27
.82
.77
.84
KLA/ATP
3.32
3.86
3.98
5.27
3.49
2.55
2.30
Casp8
KLA
ATP
ATP+KLA
NM_009812
caspase 8 (Casp8), transcript variant 1, mRNA [NM_009812]
KLA
2.41
2.53
3.20
3.26
2.75
2.78
1.57
ATP
.91
.96
.66
.67
.54
1.53
1.52
KLA/ATP
2.47
2.52
2.08
2.41
1.41
2.50
2.77
Casp9
KLA
ATP
ATP+KLA
NM_015733
caspase 9 (Casp9), mRNA [NM_015733]
KLA
.31
.31
.40
.66
.89
1.19
.91
ATP
.88
.77
.91
.59
.43
.75
.93
KLA/ATP
.26
.26
.30
.28
.80
1.06
.97
Cd14
KLA
ATP
ATP+KLA
NM_009841
CD14 antigen (Cd14), mRNA [NM_009841]
KLA
2.35
2.68
2.54
2.21
2.39
1.52
1.57
ATP
1.44
2.28
2.82
3.98
6.68
16.14
6.92
KLA/ATP
2.92
3.79
3.96
5.12
5.29
10.42
11.50
Clk1
KLA
ATP
ATP+KLA
NM_001042634
CDC-like kinase 1 (Clk1), transcript variant 1, mRNA [NM_001042634]
KLA
1.03
1.03
1.02
.95
1.01
.90
.88
ATP
1.46
2.04
2.62
2.08
2.08
.97
.81
KLA/ATP
1.17
1.61
1.92
1.80
2.08
1.12
1.04
Cxcl1
KLA
ATP
ATP+KLA
NM_008176
chemokine (C-X-C motif) ligand 1 (Cxcl1), mRNA [NM_008176]
KLA
36.87
30.25
15.74
8.84
5.41
3.01
5.84
ATP
2.77
8.26
128.38
289.44
262.38
218.83
26.91
KLA/ATP
41.06
56.76
91.82
164.83
91.44
77.89
79.05
Cxcl2
KLA
ATP
ATP+KLA
NM_009140
chemokine (C-X-C motif) ligand 2 (Cxcl2), mRNA [NM_009140]
KLA
20.11
17.63
13.50
7.78
9.14
3.98
10.85
ATP
10.96
27.84
145.37
396.18
303.88
165.35
21.04
KLA/ATP
33.28
74.00
189.99
348.56
93.84
68.75
64.87
Cxcl3
KLA
ATP
ATP+KLA
NM_203320
chemokine (C-X-C motif) ligand 3 (Cxcl3), mRNA [NM_203320]
KLA
35.82
43.91
31.09
16.74
3.98
2.27
2.93
ATP
1.13
1.23
3.43
12.43
126.40
310.60
215.03
KLA/ATP
36.32
44.70
46.93
50.61
18.91
95.89
296.64
Cycs
KLA
ATP
ATP+KLA
NM_007808
cytochrome c, somatic (Cycs), nuclear gene encoding mitochondrial protein, mRNA [NM_007808]
KLA
2.20
2.21
2.35
2.69
2.62
3.22
2.14
ATP
.87
.89
1.31
1.05
1.06
1.20
1.26
KLA/ATP
1.88
2.04
2.86
2.26
2.57
2.45
2.03
Cyct
KLA
ATP
ATP+KLA
NM_009989
cytochrome c, testis (Cyct), mRNA [NM_009989]
KLA
.93
1.01
1.00
.99
1.02
1.03
.96
ATP
1.01
.91
1.01
.99
.98
.95
.95
KLA/ATP
1.10
.96
.89
.89
1.10
1.05
.97
Eef1a1
KLA
ATP
ATP+KLA
NM_010106
eukaryotic translation elongation factor 1 alpha 1 (Eef1a1), mRNA [NM_010106]
KLA
.99
1.05
.96
.85
.88
.67
.57
ATP
1.05
1.05
.97
.96
.94
.82
.56
KLA/ATP
.96
.90
.88
.87
.69
.53
.34
Eef1a2
KLA
ATP
ATP+KLA
NM_007906
eukaryotic translation elongation factor 1 alpha 2 (Eef1a2), mRNA [NM_007906]
KLA
.96
.97
.92
.99
.88
.80
.87
ATP
1.03
1.13
.98
1.05
.96
.98
1.72
KLA/ATP
.95
1.02
.89
1.01
.85
1.27
1.76
Eef1g
KLA
ATP
ATP+KLA
AK011951
10 days embryo whole body cDNA, RIKEN full-length enriched library, clone:2610301D06 product:ELONGATION FACTOR 1-GAMMA (EF-1-GAMMA) (EEF-1B GAMMA) homolog [Mus musculus], full insert sequence [AK011951]
KLA
.90
.88
.63
.79
.52
.44
.76
ATP
1.14
1.15
1.30
1.18
1.00
.37
.54
KLA/ATP
.81
.93
.98
.88
.63
.29
.20
Eef1g
KLA
ATP
ATP+KLA
NM_026007
eukaryotic translation elongation factor 1 gamma (Eef1g), mRNA [NM_026007]
KLA
.84
.86
.87
.73
.73
.63
.78
ATP
1.02
1.05
.87
.81
.87
.69
.52
KLA/ATP
.97
.95
.76
.68
.64
.51
.33
Hbs1l
KLA
ATP
ATP+KLA
NM_019702
Hbs1-like (S. cerevisiae) (Hbs1l), transcript variant 1, mRNA [NM_019702]
KLA
1.22
1.17
1.11
1.16
1.10
1.04
1.07
ATP
.93
.94
1.03
.92
1.21
1.46
.91
KLA/ATP
1.09
1.12
1.21
1.00
1.19
1.30
.99
Hsf1
KLA
ATP
ATP+KLA
NM_008296
heat shock factor 1 (Hsf1), mRNA [NM_008296]
KLA
.95
.89
.86
.75
.82
.78
1.11
ATP
1.17
1.16
1.05
1.17
1.06
.96
.95
KLA/ATP
1.12
1.03
.85
.95
.73
.62
.62
Hsf1
KLA
ATP
ATP+KLA
Z49206
gb|M.musculus mRNA for heat shock factor 1-alpha. [Z49206]
KLA
1.08
1.12
1.13
1.02
1.11
1.08
1.06
ATP
1.01
1.13
1.01
1.29
1.20
1.04
1.14
KLA/ATP
1.15
1.18
1.12
1.35
1.20
1.17
1.32
Hspa1a
KLA
ATP
ATP+KLA
NM_010479
heat shock protein 1A (Hspa1a), mRNA [NM_010479]
KLA
7.88
6.99
4.47
5.18
7.81
11.47
4.14
ATP
1.88
5.62
43.42
58.76
55.53
28.89
9.13
KLA/ATP
7.40
7.62
28.23
54.12
70.14
43.09
22.49
Hspa1b
KLA
ATP
ATP+KLA
NM_010478
heat shock protein 1B (Hspa1b), mRNA [NM_010478]
KLA
5.01
4.73
3.77
3.62
4.81
6.53
3.12
ATP
1.34
3.07
14.11
17.14
17.51
11.21
4.82
KLA/ATP
5.04
5.15
11.63
19.94
20.84
15.79
9.30
Hspa1l
KLA
ATP
ATP+KLA
NM_013558
heat shock protein 1-like (Hspa1l), mRNA [NM_013558]
KLA
.98
1.04
1.10
1.21
1.51
1.97
1.86
ATP
1.03
1.08
1.07
1.14
.93
1.21
1.89
KLA/ATP
1.06
1.01
.99
1.09
.97
1.39
2.87
Hspa2
KLA
ATP
ATP+KLA
NM_008301
heat shock protein 2 (Hspa2), transcript variant 1, mRNA [NM_008301]
KLA
.98
.97
1.12
1.23
1.20
1.72
1.38
ATP
1.01
1.10
1.45
3.12
2.45
1.98
.98
KLA/ATP
.99
1.12
1.52
2.60
2.89
2.62
1.18
Hspa8
KLA
ATP
ATP+KLA
NM_031165
heat shock protein 8 (Hspa8), mRNA [NM_031165]
KLA
1.00
.98
1.27
1.18
1.45
1.60
1.31
ATP
1.22
1.18
1.07
1.44
1.07
.53
.57
KLA/ATP
1.18
1.22
1.14
1.08
.93
.82
.77
Hspd1
KLA
ATP
ATP+KLA
NM_010477
heat shock protein 1 (chaperonin) (Hspd1), nuclear gene encoding mitochondrial protein, mRNA [NM_010477]
KLA
.86
.89
.76
.67
.65
.60
.91
ATP
1.12
1.15
.98
.92
.91
.71
.64
KLA/ATP
.86
.97
.82
.74
.56
.38
.34
Il12a
KLA
ATP
ATP+KLA
NM_008351
interleukin 12a (Il12a), mRNA [NM_008351]
KLA
2.37
2.47
2.17
1.49
1.46
1.12
1.20
ATP
1.01
.97
1.12
1.07
1.02
1.07
1.06
KLA/ATP
2.01
2.76
2.54
1.70
1.08
1.10
1.27
Il12b
KLA
ATP
ATP+KLA
NM_008352
interleukin 12b (Il12b), mRNA [NM_008352]
KLA
194.79
211.32
198.97
173.01
142.24
40.28
3.10
ATP
1.05
1.10
1.59
1.99
2.71
2.72
1.52
KLA/ATP
191.27
223.23
280.10
224.29
183.03
68.43
10.69
Il18
KLA
ATP
ATP+KLA
NM_008360
interleukin 18 (Il18), mRNA [NM_008360]
KLA
12.14
11.96
12.28
12.96
12.23
7.84
2.40
ATP
1.06
.96
1.13
1.04
.92
1.67
2.29
KLA/ATP
11.55
11.63
13.03
9.98
9.08
6.50
6.72
Il1b
KLA
ATP
ATP+KLA
NM_008361
interleukin 1 beta (Il1b), mRNA [NM_008361]
KLA
149.78
133.59
100.91
116.58
86.48
89.37
64.72
ATP
3.49
13.96
61.44
70.91
82.12
162.79
28.18
KLA/ATP
130.32
139.00
219.12
148.17
165.44
172.57
146.98
Il6
KLA
ATP
ATP+KLA
NM_031168
interleukin 6 (Il6), mRNA [NM_031168]
KLA
352.99
378.70
276.81
168.47
59.99
18.66
8.27
ATP
1.04
1.08
2.28
3.69
30.40
161.93
2.11
KLA/ATP
334.28
528.66
###.##
935.86
302.45
355.36
99.65
Itgam
KLA
ATP
ATP+KLA
NM_001082960
integrin alpha M (Itgam), transcript variant 1, mRNA [NM_001082960]
KLA
1.04
1.12
1.14
1.07
1.54
1.80
1.72
ATP
1.17
1.19
.97
1.16
.86
.65
1.33
KLA/ATP
1.19
1.19
.94
1.06
.64
.59
1.08
Itgam
KLA
ATP
ATP+KLA
NM_008401
integrin alpha M (Itgam), transcript variant 2, mRNA [NM_008401]
KLA
1.20
1.16
1.21
1.34
1.59
1.79
1.64
ATP
1.15
1.16
.94
1.20
1.00
.78
1.25
KLA/ATP
1.32
1.37
1.29
1.14
.84
.75
1.16
Itgb2
KLA
ATP
ATP+KLA
NM_008404
integrin beta 2 (Itgb2), mRNA [NM_008404]
KLA
.78
.78
.97
.74
1.04
.94
1.14
ATP
1.24
1.23
.79
.95
1.12
.84
1.10
KLA/ATP
.99
1.01
.60
.83
.78
.73
.99
Itgb2l
KLA
ATP
ATP+KLA
NM_008405
integrin beta 2-like (Itgb2l), mRNA [NM_008405]
KLA
.87
.98
.98
1.00
1.05
1.07
1.10
ATP
1.24
1.23
1.13
1.14
1.29
1.05
1.05
KLA/ATP
1.02
1.08
1.08
1.06
.98
.93
.95
Mm.11689
4
KLA
ATP
ATP+KLA
124248589
Unknown
KLA
.85
.82
.79
.95
.77
.84
.58
ATP
1.04
1.03
.99
.93
.82
.79
.78
KLA/ATP
.92
.86
.85
.79
.78
.79
.64
Mm.31188
4
KLA
ATP
ATP+KLA
146198620
Unknown
KLA
.69
.70
.77
1.02
1.29
2.04
1.80
ATP
.91
.82
.91
.83
1.09
2.72
1.14
KLA/ATP
.65
.57
.81
.73
.88
2.07
3.86
Mm.38049
KLA
ATP
ATP+KLA
118130391
Unknown
KLA
.67
.65
.73
.92
.63
.81
.76
ATP
.93
.92
1.08
.54
.45
1.48
1.56
KLA/ATP
.57
.65
.98
.67
.44
.78
1.16
Mm.41274
5
KLA
ATP
ATP+KLA
110681696
Unknown
KLA
.97
1.07
1.11
1.07
1.38
1.63
1.35
ATP
1.06
1.09
1.05
1.29
1.04
.50
.56
KLA/ATP
1.11
1.12
1.04
1.11
.92
.83
.74
Mm.6898
KLA
ATP
ATP+KLA
114431261
Unknown
KLA
1.64
1.74
1.72
2.04
2.10
3.30
4.37
ATP
.91
.89
1.30
1.30
1.20
1.74
2.92
KLA/ATP
1.55
1.79
2.35
1.74
2.10
4.16
7.14
Myd88
KLA
ATP
ATP+KLA
NM_010851
myeloid differentiation primary response gene 88 (Myd88), mRNA [NM_010851]
KLA
3.35
3.51
3.91
4.13
4.13
3.62
2.53
ATP
.99
.96
.79
.75
.93
2.15
1.60
KLA/ATP
3.37
3.52
3.52
3.48
2.81
3.03
3.33
Naip1
KLA
ATP
ATP+KLA
NM_008670
NLR family, apoptosis inhibitory protein 1 (Naip1), mRNA [NM_008670]
KLA
.99
.97
1.00
.97
.95
1.23
2.04
ATP
1.01
1.01
.99
1.10
.96
1.05
1.13
KLA/ATP
1.00
.99
1.00
.96
.99
1.51
2.34
Naip2
KLA
ATP
ATP+KLA
NM_010872
NLR family, apoptosis inhibitory protein 2 (Naip2), transcript variant 1, mRNA [NM_010872]
KLA
1.34
1.30
1.51
1.87
2.03
2.04
2.38
ATP
1.23
1.14
1.07
.78
1.36
4.78
1.82
KLA/ATP
1.53
1.56
1.46
1.11
1.50
4.78
5.42
Naip5
KLA
ATP
ATP+KLA
NM_010870
NLR family, apoptosis inhibitory protein 5 (Naip5), mRNA [NM_010870]
KLA
1.26
1.22
1.40
1.37
1.81
2.01
1.38
ATP
1.00
.96
1.17
1.14
.84
1.12
.95
KLA/ATP
1.27
1.29
1.57
1.38
1.60
2.00
1.76
Nfkb1
KLA
ATP
ATP+KLA
BC050841
nuclear factor of kappa light chain gene enhancer in B-cells 1, p105, mRNA (cDNA clone IMAGE:6392793), complete cds. [BC050841]
KLA
5.81
4.96
4.77
3.21
3.37
2.00
1.71
ATP
1.39
1.52
3.25
12.63
13.64
4.80
1.08
KLA/ATP
7.21
8.69
19.53
23.93
11.70
2.85
2.01
Nfkb1
KLA
ATP
ATP+KLA
M57999
gb|Mouse transcription factor NF-kappa-B DNA binding subunit mRNA, complete cds. [M57999]
KLA
8.55
7.87
7.35
6.13
3.51
1.85
1.38
ATP
.98
.96
1.21
3.06
5.29
4.67
.69
KLA/ATP
7.32
7.20
8.71
10.82
5.55
2.77
1.54
Nfkb2
KLA
ATP
ATP+KLA
NM_019408
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2, p49/p100 (Nfkb2), mRNA [NM_019408]
KLA
7.31
7.92
7.95
6.42
6.41
4.42
2.81
ATP
.99
.98
.72
1.48
2.80
5.31
1.44
KLA/ATP
8.25
7.93
6.51
7.68
5.08
4.38
4.86
Nfkbia
KLA
ATP
ATP+KLA
NM_010907
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (Nfkbia), mRNA [NM_010907]
KLA
18.65
18.46
13.63
17.88
14.25
9.17
7.92
ATP
.91
1.09
7.11
32.39
17.44
10.49
1.72
KLA/ATP
15.57
17.66
15.73
23.91
13.83
10.73
9.48
Nlrc4
KLA
ATP
ATP+KLA
NM_001033367
NLR family, CARD domain containing 4 (Nlrc4), mRNA [NM_001033367]
KLA
.81
.77
.85
.98
1.35
1.96
1.86
ATP
1.09
.92
.83
.90
1.19
1.63
1.12
KLA/ATP
.83
.72
.90
.94
.92
1.64
3.46
Pycard
KLA
ATP
ATP+KLA
NM_023258
PYD and CARD domain containing (Pycard), mRNA [NM_023258]
KLA
1.48
1.44
1.62
1.81
1.80
1.69
.94
ATP
.89
.88
1.00
.84
.52
.30
.62
KLA/ATP
1.32
1.34
1.65
1.38
1.14
.50
.41
Rab1
KLA
ATP
ATP+KLA
NM_008996
RAB1, member RAS oncogene family (Rab1), mRNA [NM_008996]
KLA
1.25
1.21
1.49
1.54
1.78
1.58
1.14
ATP
1.01
.85
.50
.57
1.07
1.29
1.09
KLA/ATP
1.25
1.12
.84
.84
1.32
1.69
1.15
Rab1b
KLA
ATP
ATP+KLA
NM_029576
RAB1B, member RAS oncogene family (Rab1b), mRNA [NM_029576]
KLA
.81
.83
.82
.73
.78
.77
.95
ATP
1.01
1.17
1.13
1.49
1.09
.77
1.13
KLA/ATP
.84
.92
.69
1.08
.72
.79
.98
Rela
KLA
ATP
ATP+KLA
NM_009045
v-rel reticuloendotheliosis viral oncogene homolog A (avian) (Rela), mRNA [NM_009045]
KLA
2.05
2.05
2.07
1.75
1.83
1.58
1.33
ATP
1.03
1.08
1.10
1.44
1.61
2.48
1.05
KLA/ATP
2.17
2.27
2.05
2.47
1.93
2.35
2.02
Sar1a
KLA
ATP
ATP+KLA
NM_009120
SAR1 gene homolog A (S. cerevisiae) (Sar1a), mRNA [NM_009120]
KLA
1.66
1.79
1.74
1.76
1.68
1.55
1.50
ATP
1.00
.92
1.03
1.06
1.54
2.40
2.04
KLA/ATP
1.76
1.85
1.67
1.85
1.98
2.32
3.21
Sar1b
KLA
ATP
ATP+KLA
NM_025535
SAR1 gene homolog B (S. cerevisiae) (Sar1b), mRNA [NM_025535]
KLA
1.22
1.22
1.22
1.25
1.16
1.20
1.31
ATP
1.03
1.07
1.22
1.21
1.20
1.02
1.15
KLA/ATP
1.32
1.17
1.22
1.22
1.15
1.12
1.09
Sec22b
KLA
ATP
ATP+KLA
NM_011342
SEC22 vesicle trafficking protein homolog B (S. cerevisiae) (Sec22b), mRNA [NM_011342]
KLA
1.18
1.18
1.22
1.35
1.29
1.23
1.19
ATP
1.06
1.03
1.09
1.02
1.34
2.84
1.53
KLA/ATP
1.17
1.27
1.42
1.29
1.28
1.69
1.90
Tlr2
KLA
ATP
ATP+KLA
NM_011905
toll-like receptor 2 (Tlr2), mRNA [NM_011905]
KLA
13.65
11.82
8.87
7.95
4.67
2.78
2.33
ATP
1.06
1.24
2.76
6.28
11.55
13.82
.67
KLA/ATP
13.11
12.91
14.48
13.84
14.18
11.14
2.78
Tlr4
KLA
ATP
ATP+KLA
NM_021297
toll-like receptor 4 (Tlr4), mRNA [NM_021297]
KLA
.69
.61
.75
.94
.64
.81
.73
ATP
.95
.90
1.12
.56
.47
1.51
1.53
KLA/ATP
.57
.62
1.01
.64
.39
.73
1.13
Tlr5
KLA
ATP
ATP+KLA
AF186107
toll-like receptor 5 (Tlr5) mRNA, complete cds [AF186107]
KLA
.78
.75
.84
.78
.72
.74
.43
ATP
.98
1.07
.99
.95
.79
.66
.61
KLA/ATP
.79
.81
.77
.73
.73
.67
.50
Tnf
KLA
ATP
ATP+KLA
NM_013693
tumor necrosis factor (Tnf), mRNA [NM_013693]
KLA
13.35
12.76
10.71
9.03
10.64
7.39
8.32
ATP
2.01
2.48
8.27
19.20
9.72
4.09
1.49
KLA/ATP
12.72
15.76
12.73
17.34
5.10
3.61
6.07
Vcp
KLA
ATP
ATP+KLA
NM_009503
valosin containing protein (Vcp), mRNA [NM_009503]
KLA
.89
.99
.95
.88
.92
.97
1.04
ATP
1.03
1.02
.80
.71
1.05
1.42
.74
KLA/ATP
.99
1.02
.79
.71
.85
1.05
.65